Fact sheet: JPM Gbl Healthcare

Fund information

Fund name
JPM Global Healthcare A Acc NAV USD
Fund company manager
JPMorgan Asset Mgmt (Europe) S
Fund type
SIB
Fund manager(s)
Premal PAJWANI
since 24/06/2014
Anne Marden
since 20/10/2009
Matthew Cohen
since 05/01/2015
Fund objective
To achieve a return by investing primarily in pharmaceutical, biotechnology, healthcare services, medical technology and life sciences companies ("Healthcare Companies"), globally.
Benchmark
MSCI World Healthcare
Investment style
None
Investment method
Shares

Quick stats

1 Year return

17.42 %

1 Year rank in sector

5/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 2.8 b

FE Risk score

149

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • North America
    71.9%
  • Europe & Middle East
    21%
  • UK
    4.7%
  • Japan
    1.2%
  • Money Market
    1.2%
  • Biotechnology/Medical
    48.6%
  • Pharmaceuticals
    32.1%
  • Health Care
    18.1%
  • Money Market
    1.2%
  • North American Equities
    72%
  • International Equities
    20.2%
  • UK Equities
    4.8%
  • Money Market
    1.7%
  • Japanese Equities
    1.3%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-2.62 %5.2 %17.42 %3.1 %101.17 %
Sector-2.72 %3.32 %11.23 %12.3 %97.73 %
Rank within sector18 / 3011 / 305 / 2919 / 2612 / 22
Quartile th3 rd2 nd1 st3 rd3 rd

Calendar performance

YTD-20172016201520142013
Fund17.34 %-15.42 %2.14 %22.01 %61.04 %
Sector13.59 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector10 / 2922 / 2922 / 2618 / 234 / 22
Quartile th2 nd4 th4 th4 th1 st

Risk statistics

Alpha-2.91
Beta0.9
Sharpe-0
Volatility14.21
Tracking error4.05
Information ratio-0.81
R-Squared0.93

Price movement

52 week high307.08
52 week low244.86
Current bid price0
Current offer price0
Current mid price294.62

Holdings by region

  • 71.9% North America
  • 21% Europe & Middle East
  • 4.7% UK
  • 1.2% Japan
  • 1.2% Money Market

Holdings by sector

  • 48.6% Biotechnology/Medical
  • 32.1% Pharmaceuticals
  • 18.1% Health Care
  • 1.2% Money Market

Holdings by asset type

  • 72% North American Equities
  • 20.2% International Equities
  • 4.8% UK Equities
  • 1.7% Money Market
  • 1.3% Japanese Equities

Individual holdings

  • 6.3% UNITEDHEALTH GROUP INC
  • 4.8% ROCHE HLDG AG
  • 4.5% CELGENE CORP
  • 3.9% BAYER AG
  • 3.8% BRISTOL MYERS SQUIBB SA
  • 3% PFIZER INC
  • 3% SANOFI
  • 2.7% LILLY (ELI) & CO
  • 2.7% VERTEX PHARMACEUTICAL
  • 2.6% ALLERGAN INC